Skip to content

Postoperative Complications Following Total Knee Arthroplasty

Comparison of Effects of Combined Spinoepidural and General Anesthesia Effects on Incidence of Postoperative Complications Following Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03746444
Enrollment
130
Registered
2018-11-19
Start date
2018-11-20
Completion date
2018-12-25
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee

Keywords

total knee arthroplasty, general anesthesia, neuraxial anesthesia, complications

Brief summary

The aim of this study is to investigate the effect of combined spinoepidural and general anesthesia on the incidence of postoperative complications following total knee arthroplasty

Detailed description

Total knee arthroplasty is known to cause complications (pulmonary thromboembolism, acute kidney injury, arryhthmias and infection). The investigators aimed to study the effects of two different anesthesia techniques, i.e. combined spinoepidural anesthesia and general anesthesia on the incidence of postoperative complications such as arrhythmia, pulmonary thrombeoembolism, infection, acute kidney injury and mortality.

Interventions

OTHERGeneral Anesthesia

The patients in general anesthesia group will undergo general anesthesia

OTHERRegional Anesthesia

The patients in Group R will be given combined spinoepidural anesthesia

Sponsors

Ufuk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo elective unilateral total knee arthroplasty

Exclusion criteria

* Patient refusal * Scheduled for bilateral or unilateral unicondylar knee arthroplasty * Known history of allergy to drugs used in the study * Severe systemic disease * Morbid obesity (BMI\>30) * History of renal dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Acute Kidney InjuryPostoperative first dayNumber of participants with new onset acute kidney injury
Pulmonary ThromboembolismPostoperative first dayNumber of participants with new onset pulmonary thromboembolism
InfectionPostoperative first dayNumber of participants with new onset infection
ArryhthmiaPostoperative first dayNumber of participants with new onset arryhthmia requiring treatment
DeathPostoperative first dayNumber of participants with mortality

Countries

Turkey (Türkiye)

Contacts

Primary ContactPerihan Ekmekçi, MD
erdogduperi@gmail.com+903122044000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026